Tata Chemicals Share Price in Focus on May 8; Sees Profit Dip in FY25

Tata Chemicals Limited has announced its financial results for the fourth quarter and full year ended March 31, 2025. 

Post the announcement, on May 8, 2025, Tata Chemicals share price opened at ₹821.00, down from its previous close of ₹826.20. At 9:41 AM, the share price of Tata Chemicals was trading at ₹836.00, up by 1.19% on the NSE. 

Q4 FY25 Performance Affected by Global Headwinds 

In Q4 FY25, Tata Chemicals recorded a consolidated revenue from operations of ₹3,509 crore, marking a 1% year-on-year increase. Despite this marginal growth, the company faced sustained pricing pressure across geographies, which impacted profitability. EBITDA dropped to ₹327 crore from ₹443 crore in the same quarter last year.  

The company also reported a net loss of ₹12 crore (before exceptional items and NCI) compared to a profit of ₹145 crore in Q4 FY24. 

One of the significant factors contributing to the subdued quarterly performance was the cessation of soda ash operations at the Lostock plant in the UK. This led to an exceptional charge of ₹55 crore in Q4 FY25. Additionally, gross debt increased to ₹7,072 crore as of March 31, 2025, primarily due to higher working capital loans in India, the US, and the UK. 

Full-Year FY25 Summary 

For the full financial year, Tata Chemicals reported a consolidated revenue of ₹14,887 crore, slightly lower than ₹15,421 crore in FY24. EBITDA stood at ₹1,953 crore, down from ₹2,847 crore, mainly due to compressed margins amid lower product pricing. 

Despite these challenges, the company posted a Profit After Tax of ₹479 crore (before exceptional items and NCI). Exceptional charges for FY25 totaled ₹125 crore, related to closure expenses of the Lostock plant.  

On the positive side, Tata Chemicals successfully commissioned significant capacity expansions, including a 230kT soda ash and 140kT bicarb facility in India and a 70kT pharma-grade salt facility in the UK. 

Management Commentary 

Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited, said, “Market conditions remain challenging even as India continues to grow while China, US and Western Europe are witnessing slight declines due to reduced demand for flat and container glass. In other regions, Asia (excluding China and India) and Americas (excluding USA) demand is robust, while slight decline is observed in demand of Africa. Though demand – supply balance softens, tariff uncertainties will continue to weigh on market, medium- and long-term outlook remains positive driven by sustainability trends.”  

 He further added, “The company’s overall performance is lower compared to Q4FY24, mainly due to pricing pressure in all geographies. During the FY25, Company commissioned 230kT Soda Ash and 140kT Bicarb capacity in Mithapur, India. In a move to focus UK operations to high-grade value-added products 70kT pharma grade salt capacity was commissioned in Middlewich, UK.”  

“Our endeavor is to Excel in operations through innovation, digitization and customer delight. We continue our journey to Embed sustainability guided by Project Aalingana. Our focus to Expand the core while being calibrated will also include broadening the portfolio,” said R. Mukundan.  

Also Read: Tata Motors Announces Shareholder Approval for Demerger!

Conclusion 

While FY25 posed challenges for Tata Chemicals due to global pricing pressure and restructuring costs, the company remains focused on capacity expansion and long-term growth. Strategic investments in India and the UK signal confidence in future demand recovery and operational efficiency. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.